Manulife (Manufacturers Life Insurance)’s Revance Therapeutics, Inc. RVNC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
|
|||||
|
2024
Q4 | $120K | Sell |
|
|||||
|
2024
Q3 | $211K | Sell |
|
|||||
|
2024
Q2 | $109K | Buy |
|
|||||
|
2024
Q1 | $161K | Sell |
|
|||||
|
2023
Q4 | $354K | Sell |
|
|||||
|
2023
Q3 | $477K | Buy |
|
|||||
|
2023
Q2 | $843K | Buy |
|
|||||
|
2023
Q1 | $1.02M | Buy |
|
|||||
|
2022
Q4 | $565K | Buy |
|
|||||
|
2022
Q3 | $741K | Sell |
|
|||||
|
2022
Q2 | $386K | Sell |
|
|||||
|
2022
Q1 | $567K | Sell |
|
|||||
|
2021
Q4 | $603 | Buy |
|
|||||
|
2021
Q3 | $1.02M | Sell |
|
|||||
|
2021
Q2 | $1.17M | Buy |
|
|||||
|
2021
Q1 | $1M | Sell |
|
|||||
|
2020
Q4 | $1.07M | Buy |
|
|||||
|
2020
Q3 | $894K | Buy |
|
|||||
|
2020
Q2 | $862K | Buy |
|
|||||
|
2020
Q1 | $461K | Buy |
|
|||||
|
2019
Q4 | $433K | Sell |
|
|||||
|
2019
Q3 | $389K | Sell |
|
|||||
|
2019
Q2 | $367K | Buy |
|
|||||
|
2019
Q1 | $403K | Buy |
|
|||||
|
2018
Q4 | $417K | Sell |
|
|||||
|
2018
Q3 | $552K | Sell |
|
|||||
|
2018
Q2 | $680K | Buy |
|
|||||
|
2018
Q1 | $630K | Buy |
|
|||||
|
2017
Q4 | $650K | Buy |
|
|||||
|
2017
Q3 | $495K | Sell |
|
|||||
|
2017
Q2 | $483K | Buy |
|
|||||
|
2017
Q1 | $354K | Buy |
|
|||||
|
2016
Q4 | $311K | Buy |
|
|||||
|
2016
Q3 | $238K | Sell |
|
|||||
|
2016
Q2 | $203K | Buy |
|
|||||
|
2016
Q1 | $218K | Buy |
|
|||||
|
2015
Q4 | $366 | Buy |
|
|||||
|
2015
Q3 | $313 | Buy |
|
|||||
|
2015
Q2 | $332 | Buy |
|
|||||
|
2015
Q1 | $140 | Buy |
|
|||||
|
2014
Q4 | $111 | Buy |
|
|||||
|
2014
Q3 | $109 | Buy |
|
|||||
|
2014
Q2 | $151K | Buy |
|